-
Category
Proteins And Peptides
-
Clonality
N/A
-
Raised in
Synthetic
-
Target
AKR1C2 Blocking
-
Immunogen
see included datasheet or contact us
-
Species reactivity
Human, Mouse, Rat (for other species please inquire)
-
Purification
Affinity purified
-
Applications
WB (for other applications please contact us)
-
Stock availability
Shipped within 5-10 working days.
-
Storage conditions
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
Footnote
This product is for research use only.
-
-
Test
You can block the antibody by the specific target amino acid sequence of peptide.
-
Properties
blocking peptide
-
Description
Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
Gene target
-
Gene symbol
AKR1C2
-
Short name
AKR1C2 Blocking Peptide
-
Technique
blocking peptide, Blocking, peptide, blocking peptides, Abbexa made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
-
Label
No Label
-
Alternative name
aldo-keto reductase family 1, member complement component 2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-a hydroxysteroid dehydrogenase, classification III) inhibiting short protein sequence
-
Alternative technique
control, peptides
-
Alternative to gene target
aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III), AKR1C-pseudo and BABP and DD and DD2 and DDH2 and HAKRD and HBAB and MCDR2 and SRXY8 and TDD, AKR1C2 and IDBG-47297 and ENSG00000151632 and 1646, oxidoreductase activity, Cytoplasm
-
